Results 201 to 210 of about 23,251 (254)

Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern era. [PDF]

open access: yesIntern Med J
Barge L   +22 more
europepmc   +1 more source

Individualised but Specific Exercise Training Improves Physiologic Reserve and Reduces Frailty in Older Adults with Chronic Lymphocytic Leukaemia: A 12-Week Pragmatic Randomised Controlled Trial

open access: yes
Miles EE   +12 more
europepmc   +1 more source

Chronic Lymphocytic Leukaemia

Lancet, The, 2018
Important advances in understanding the pathogenesis of chronic lymphocytic leukaemia in the past two decades have led to the development of new prognostic tools and novel targeted therapies that have improved clinical outcome. Chronic lymphocytic leukaemia is the most common type of leukaemia in developed countries, and the median age at diagnosis is ...
Tait D Shanafelt, Michael Hallek
exaly   +3 more sources

Chronic Lymphocytic Leukaemia

Lancet, The, 2008
Chronic lymphocytic leukaemia is the commonest form of leukaemia in Europe and North America, and mainly, though not exclusively, affects older individuals. It has a very variable course, with survival ranging from months to decades. Major progress has been made in identification of molecular and cellular markers that could predict disease progression ...
T J Hamblin, Guillermo Dighiero
exaly   +4 more sources

Chronic lymphocytic leukaemia

Critical Reviews in Oncology/Hematology, 2016
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia among the adults in the Western World. CLL (and the corresponding nodal entity small lymphocytic lymphoma, SLL) is classified as a lymphoproliferative disorder characterised by the relentless accumulation of mature B-lymphocytes showing a peculiar immunophenotype in the peripheral blood ...
Scarfò, Lydia   +2 more
openaire   +2 more sources

Chronic lymphocytic leukaemia

The Lancet
The last decade has seen remarkable progress in our understanding of disease biology of chronic lymphocytic leukaemia (CLL) and the development of novel targeted therapies. Randomised clinical trials have reported improved progression-free survival and overall survival with targeted therapies compared with chemoimmunotherapy, and thereby the role of ...
Nitin, Jain   +2 more
  +6 more sources

Chronic Lymphocytic Leukaemia

Medicine, 2000
Abstract Chronic lymphocytic leukaemia (CLL) results from neoplastic proliferation of a mature B lymphocyte. It is defined by a persistent lymphocytosis of more than 10 × 10 9 /litre and lymphoid infiltration of the bone marrow of at least 40%. With the use of immunological markers, it is possible to establish the diagnosis of CLL by B cell clonality,
Estella Matutes, Claire Dearden
openaire   +1 more source

Chronic Lymphocytic Leukaemia with Binucleated Lymphocytes

Leukemia & Lymphoma, 1997
Chronic lymphocytic leukaemia (CLL) is a monoclonal proliferation usually involving B cells and composed of mature lymphoid cells. Distinct morphologic subtypes have been recognized according to lymphocyte size, nuclear:cytoplastic ratio and nucleolus.
I, Amouroux   +5 more
openaire   +2 more sources

Lymphocyte Kinetics in Chronic Lymphocytic Leukaemia

British Journal of Haematology, 1970
51‐Chromium was used to study lymphocyte kinetics in patients with chronic lymphocytic leukaemia. Lymphocytes were found to equilibrate with a pool larger than that accounted for by blood volume and the blood lymphocyte count. Lymphocyte disappearance from the blood stream was exponential and complex, with an initial large rapid component and a smaller
J L, Spivak, S, Perry
openaire   +2 more sources

Home - About - Disclaimer - Privacy